110 days ago
With just three patients in phase 1 trials Hemogenyx (HEMO) is at an incredibly early stage of drug development. But at least it is doing something, until recently it has just been a lifestyle business for its cock of a CEO Vlad Sandler. Today a prospectus is out, allowing yet more confetti to start trading. Turn to page 7
120 days ago
The maths really are not that hard. Dianne Abbott could do them. Okay I exaggerate she could not. But the thesis stands. Just look at results for lifestyle pretend biotech company Hemogenyx (HEMO) for the six months to June 30.
195 days ago
Shares in the worthless lifestyle company Hemogenyx (HEMO) have raced ahead by 68% today to 316p after a placing raising gross proceeds of £570,000 at 180p was announced yesterday. Lets call it £520,000 net and that tells you that ghastly boss Vald Sandler will be passing the hat around yet again before Christmas.
951 days ago
Yesterday I detailed the catalogue of schoolboy accounting errors in the final results from Limitless Earth (LME). I made the Nomad aware but as this is AIM it seems as if nobody cares. Perhaps dropping a note to the FRC might concentrate a few minds round at Cairn Financial? The annual report has now been published and fresh horrors emerge.
3048 days ago
No I really want to be sick. The day started so well with Joshua, myself and more fit young mums making a paper image of Colin the Dog. But then I just got sick so hence the lack of content from me today. After this podcast goes up it is back to bed. On bear cast today a demolition of minus 99.5% lifestyle company Arian Silver (AGQ), 13 Energy (i3E), today's spoof from Magnolia (MAGP), a "fucked if I know" response from me on R4E (R4E) - a share we own - and a look at today's dire news from one of Jim Mellon's many AIM dogs FastForward (FFWD).
